Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00185068 · ClinicalTrials.gov registry record · Phase 4

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

A Phase 4 study of Hypertension, sponsored by Daiichi Sankyo.

Completed
Registry status
Phase 4
Development phase
110
Enrollment target
16
Study locations

NCT00185068 is a Phase 4 study of Hypertension that has completed, run by Daiichi Sankyo. The registered enrollment target is 110 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The trial reports 16 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00185068, a Phase 4 study of Hypertension, has completed, sponsored by Daiichi Sankyo.

COMPLETED
Registry status
Phase 4
Development phase
110 participants
Enrollment target
16
Study locations

Study Summary

Effect of increasing doses of olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide on blood pressure in patients with hypertension

Conditions Studied

Hypertension

Interventions

  • DRUG Olmesartan medoxomil
  • DRUG Hydrochlorothiazide
  • DRUG Olmesartan medoxomil/hydrochlorothiazide

Study Locations (16)

California

  • - Fort Lauderdale
  • - Long Beach
  • - Roseville
  • - Sacramento
  • - Santa Anna
  • - Tustin
  • - Westlake Village

Florida

  • - DeLand
  • - Pembroke Pines

Illinois

  • - Orland Park

Louisiana

  • - New Orleans

Maine

  • - Auburn

Nebraska

  • - Omaha

New York

  • - Buffalo

Oklahoma

  • - Oklahoma City

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2004-03
Est. Completion 2004-10
Phase Phase 4

Sponsor

Daiichi Sankyo

236 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00185068

The ClinicalTrials.gov registry entry for NCT00185068 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Olmesartan medoxomil is the first listed.

NCT00185068 reports 16 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT00185068 about?

NCT00185068 is a clinical study titled "An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension". Effect of increasing doses of olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide on blood pressure in patients with hypertension

What is the current status of trial NCT00185068?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2004-03. Estimated completion is 2004-10.

What conditions does trial NCT00185068 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00185068?

The interventions under investigation include: Olmesartan medoxomil (DRUG), Hydrochlorothiazide (DRUG), Olmesartan medoxomil/hydrochlorothiazide (DRUG).

Who is sponsoring clinical trial NCT00185068?

This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00185068 being conducted?

This trial has 16 study locations across California, Florida, Illinois, Louisiana, Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.